Intestinal Colonization by a Lachnospiraceae Bacterium Contributes to the Development of Diabetes in Obese Mice

Keishi Kameyama, Kikuji Itoh

Read Intestinal Colonization by a Lachnospiraceae Bacterium Contributes to the Development of Diabetes in Obese Mice by Keishi Kameyama, Kikuji Itoh in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4262368.txt.

Introduction

Keishi Kameyama and Kikuji Itoh named a gut bacterium that pushes obese mice toward diabetes in Microbes and Environments. Gut microbes shape body weight and blood sugar, but which members drive disease, rather than merely mark it, is hard to prove. The pair isolated candidates from the faeces of hyperglycemic obese mice.

One isolate, a Lachnospiraceae strain catalogued as AJ110941, was seeded alone into germ-free ob/ob mice, which are genetically prone to obesity. Colonized mice developed higher fasting blood glucose, heavier livers and belly fat, and lower insulin with weaker beta-cell function readings than germ-free controls. A single ordinary gut resident, in other words, measurably worsened the metabolic picture in a susceptible host. The authors call for work on how the bacterium exerts that effect.

Catalog record

CREATORKeishi Kameyama, Kikuji Itoh
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4262368

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Intestinal Colonization by a Lachnospiraceae Bacterium Contributes to the Development of Diabetes in Obese Mice By Keishi Kameyama, Kikuji Itoh Published in: Microbes and Environments DOI: 10.1264/jsme2.ME14054 ABSTRACT The aim of the present study was to identify bacteria that may contribute to the onset of metabolic dysfunctions. We isolated and identified a candidate bacterium belonging to Lachnospiraceae (strain AJ110941) in the feces of hyperglycemic obese mice. The colonization of germ-free ob/ob mice by AJ110941 induced significant increases in fasting blood glucose levels as well as liver and mesenteric adipose tissue weights, and decreases in plasma insulin levels and HOMA-β values. These results indicated that the specific gut commensal bacterium AJ110941 influenced the development of obesity and diabetes in ob/ob mice with genetic susceptibility for obesity. The gut microbiota has been shown to influence host energy homeostasis, metabolism, and inflammation; thus, microbial communities within the gut are now recognized as an important environmental factor in the onset of obesity and type 2 diabetes (T2D) (5, 7, 12, 14, 23). As a consequence, interest in the development of methods to target gut microbiota as a therapy for T2D is increasing (2, 12, 18, 21). Several studies have conducted metagenomic analyses in an attempt to identify members of the gut microbial community that contribute most significantly to the progression of T2D. Qin et al. performed a metagenomic analysis on fecal samples obtained from 345 Chinese men and women with or without T2D (19). Karlsson et al. also conducted a metagenomic analysis to compare microbial communities in fecal samples collected from 145 European women who had either T2D, impaired glucose metabolism, or were healthy (13). Both of these studies reported that butyrate-producing Roseburia species and Faecalibacterium prauznitzii were rarer in subjects with T2D; however, the identified bacteria that existed in high population in T2D subjects differed between these studies (8). Cani et al. proposed that lipopolysaccharide (LPS), a cell wall component of almost all Gram-negative bacteria, may be a key substance responsible for metabolic endotoxemia, low-grade systemic inflammation, and insulin resistance in mouse models (1, 3). In support of this, a previous study reported that experimental endotoxemia induced adipose inflammation and insulin resistance in human subjects (17). We herein searched for the specific gut commensal bacterium related to metabolic syndrome using the terminal restriction fragment length polymorphism (T-RFLP) analysis of fecal samples from a mouse model of T2D. In this study, a comparison of homozygous db/db (diabetic) with heterozygous db/+ (non-diabetic) mice revealed that a specific fragment of the T-RFLP analysis was present at significantly higher levels in db/db mice than in db/+ mice. Even though ob/ob obese mice gain weight rapidly and show the symptoms of insulin resistance, most of the obese mice do not develop severe hyperglycemia compared with db/db mice (22). However, one of the ob/ob mice in the present study showed an abnormally high fasting blood glucose (FBG) level similar to db/db mice. The specific fragment observed in db/db mice was also the most prominent in the abnormally hyperglycemic ob/ob mouse. We hypothesized that the specific bacterium harboring the fragment may have contributed to the progression of T2D; therefore, we isolated and cultured the bacterium (strain AJ110941). We then determined that colonization by the isolate with the LPS producer E. coli induced hyperglycemia and the accumulation of adipose tissue in the gnotobiotic ob/ob mouse model. All experimental procedures were reviewed and approved by the Animal Care Committee of Ajinomoto Co., Inc. Male 5-week-old homozygous BKS.Cg-Dock7m +/+Leprdb/J (db/db, diabetic) mice, heterozygous control (db/+, non-diabetic) mice, and homozygous B6.V-Lepob/J (ob/ob, obese) mice were obtained from Charles River Japan (Yokohama, Japan). Male 5-week-old germ-free ob/ob mice were obtained from Sankyo Lab Service (Tokyo, Japan). These mice were housed in a controlled environment (on a 12-h light/dark cycle with lights turning off at 19:00) with free access to standard chow CRF-1 (Oriental Yeast, Tokyo, Japan) and water and kept in specific pathogen-free (SPF) or germfree/gnotobiotic conditions throughout the experimental period. Fresh feces and blood were collected from 5- and 11-week-old mice after fasting for 16 h. Blood glucose (FBG) levels were determined using DRI-CHEM 7000V (Fujifilm, Tokyo, Japan). Plasma insulin levels were determined using an ultrasensitive mouse insulin kit (Morinaga Institute of Biological Science, Yokohama, Japan). Plasma glucagon levels were determined using the Glucagon ELISA Kit Wako (Wako Pure Chemical Industries, Osaka, Japan). Insulin resistance (HOMA-IR) and β-cell function (HOMA-β) were both calculated on the basis of the fasting levels of plasma glucose and insulin according to the homeostasis model assessment (HOMA) method (16). Fresh fecal samples were collected from mice, added to 99% ethanol, and stored at −30°C. Bacterial DNA was extracted from the fecal samples using the FastDNA spin kit for soil (MP Biomedicals, Santa Ana, CA) using the FastPrep instrument (MP Biomedicals). T-RFLP analyses of the mouse gut microbiota were performed as previously described (10). Two universal primers, 27F labeled with 6-carboxyfluorescein (FAM): 5′-FAM-AGAGTTTGATCCTGGCTCAG-3′ and 1492R: 5′-GGTTACCTTGTTACGACTT-3′ were used in PCR to amplify the 16S rRNA gene coding region. Purified PCR products of the 16S rRNA gene were digested with MspI (Takara Bio, Otsu, Japan). To isolate and culture the bacterium, fresh feces were collected and immediately weighed and transferred to an anaerobic chamber. The feces were homogenized with a 50-fold volume (v/w) of an anaerobic diluent, serially diluted, and then plated on Eggerth-Gagnon (EG) agar plates (11). The agar plates were incubated at 37°C for 4 d in the anaerobic chamber. All of the colonies were identified by their fragment size, and a target colony with a fragment size of 282 bp was then selected. The colony was passaged onto new EG agar plates, and the bacterial purity of the isolate was ensured by re-streaking and microscopic observations. The 16S rRNA gene sequence of the isolated bacterium was determined as previously described (15). The sequence was assembled using GENETYX version 7 (GENETYX, Tokyo, Japan). The identification and phylogenic tree analysis of the 16S rRNA gene sequence were carried out using the Ribosomal Database Project (RDP) (6). When the mice were 8 weeks old, germ-free ob/ob mice were separated into 3 groups for the germ-free/gnotobiotic experiment: Group-1 (n=4), germ-free; Group-2 (n=4), colonization by the non-pathogenic Escherichia coli strain E-17, which had been isolated from SPF mice; Group-3 (n=4), colonization by AJ110941 with E. coli E-17. Groups-2 and -3 were then orally inoculated with E. coli E-17 or AJ110941 with E. coli E-17 (approximately 1×108 cells suspended in anaerobic PBS, respectively). Group-1 was orally administered PBS only. These mice were maintained under the germ-free or gnotobiotic conditions for 8 weeks. We compared differences in gut microbiota patterns between db/+ and db/db mice. Hyperglycemia was observed in 11-week-old, but not in 5-week-old mice (Fig. S1). The 282 bp fragment was significantly higher in db/db than db/+ mice at both 5 and 11 weeks old (Fig. S2). We then evaluated the presence of the 282 bp fragment in another metabolic syndrome model, the ob/ob mouse. The highest FBG level observed among all ob/ob mice was in Mouse Number 4 (Fig. S3). The 282 bp fragment was also more prominent in hyperglycemic Mouse Number 4 than in the normal glycemic ob/ob mouse at both 5 and 11 weeks old (Fig. S4). Based on these db/db

Read the complete text